Literature DB >> 28660444

Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?

Pasquale Esposito1, Fabrizio Grosjean2, Filippo Mangione2, Maria Valentina Domenech2, Teresa Rampino2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28660444     DOI： 10.1007/s10157-017-1437-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  5 in total

Review 1.  New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.

Authors:  D Roccatello; S Sciascia; D Di Simone; L Solfietti; C Naretto; R Fenoglio; S Baldovino; E Menegatti
Journal:  Autoimmun Rev       Date:  2016-02-11       Impact factor: 9.754

2.  Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.

Authors:  Fernando C Fervenza; Roshini S Abraham; Stephen B Erickson; Maria Valentina Irazabal; Alfonso Eirin; Ulrich Specks; Patrick H Nachman; Eric J Bergstralh; Nelson Leung; Fernando G Cosio; Marie C Hogan; John J Dillon; LaTonya J Hickson; Xujian Li; Daniel C Cattran
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-12       Impact factor: 8.237

3.  Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.

Authors:  Mai Sato; Koichi Kamei; Masao Ogura; Kenji Ishikura; Shuichi Ito
Journal:  Clin Exp Nephrol       Date:  2017-04-22       Impact factor: 2.801

4.  Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.

Authors:  Paolo Cravedi; Piero Ruggenenti; Maria Chiara Sghirlanzoni; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

5.  Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.

Authors:  Gabriella Moroni; Federica Depetri; Lucia Del Vecchio; Beniamina Gallelli; Francesca Raffiotta; Elisa Giglio; Francesca Brunini; Marco D'Amico; Selena Longhi; Antonella Radice; Piergiorgio Messa; Renato Alberto Sinico
Journal:  Nephrol Dial Transplant       Date:  2017-10-01       Impact factor: 5.992
  5 in total
  2 in total

1.  Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis.

Authors:  Lan Huang; Qiao-Rong Dong; Ya-Juan Zhao; Gui-Cai Hu
Journal:  Int Urol Nephrol       Date:  2020-09-17       Impact factor: 2.370

2.  The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy.

Authors:  Zuhui Su; Yabin Jin; Yu Zhang; Zhanwen Guan; Huishi Li; Xiangping Chen; Chao Xie; Chuling Zhang; Xiaofen Liu; Peixian Li; Peiyi Ye; Lifang Zhang; Yaozhong Kong; Wei Luo
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.